Protein phosphorylation: A potential target in glioma development.
Yu PiChang-Le FangZhang-Yu SuPublished in: Ibrain (2022)
Glioma is one of the most common primary brain tumors, and mortality due to this disease is second only to cardiovascular and cerebrovascular diseases. In traditional surgery, it is difficult to eradicate glioma; often recurrence increases its malignant degree, leading to a large number of patients killed by this disease. It is one of the most important subjects to study its pathogenesis and explore effective treatment methods. Research on glioma mechanisms mainly focuses on the effect of DNA methylation in epigenetics. Although there are many studies on protein phosphorylation, there is no overall regulatory mechanism. Protein phosphorylation regulates a variety of cell functions, such as cell growth, division and differentiation, and apoptosis. As a consequence, protein phosphorylation plays a leading part in various activities of glioma, and can also be used as a target to regulate the development of glioma. This review is aimed at studying the effect of protein phosphorylation on glioma, understanding the pathological mechanism, and an in-depth analysis of it. The following is a discussion on glioma growth, migration and invasion, resistance and death in phosphorylation, and the possibility of treating glioma by phosphorylation.
Keyphrases
- dna methylation
- protein kinase
- protein protein
- end stage renal disease
- binding protein
- oxidative stress
- gene expression
- minimally invasive
- type diabetes
- cell death
- chronic kidney disease
- peritoneal dialysis
- atrial fibrillation
- cell proliferation
- acute coronary syndrome
- mesenchymal stem cells
- cardiovascular events
- coronary artery disease
- newly diagnosed
- combination therapy
- cell cycle arrest
- patient reported